Disease-Modifying Therapies for Duchenne Muscular Dystrophy: An Update for Managed Care Professionals

https://www.pharmacytimes.org/on-demand/diseasemodifying-therapies-for-duchenne-muscular-dystrophy-an-update-for-managed-care-professionals-ondemand-webinar

Related Videos

Related Content

Advertisement

January 12th 2025

Designing Care for the Underserved Creates Higher-Value Health Solutions

Maggie L. Shaw

In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.

December 31st 2024

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

Christina Mattina

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

January 12th 2025

Early Onset Active IBD Linked to Higher Rates of Psychiatric Disorders, Medication Use

Brooke McCormick

Early onset active inflammatory bowel disease (IBD) is associated with significantly higher rates of psychiatric disorders and increased use of psychotropic medications.

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

January 12th 2025

Standardized Measurements Needed for AAVs in Gene Therapy, Study Finds

Rose McNulty

Common measurements for modified adeno-associated viruses (AAVs), a gene therapy delivery method, showed substantial variation in accuracy and precision.

January 11th 2025

Skin Cancer Disparities Persist in Latine/Hispanic Population

Hayden E. Klein

Latine individuals in the US face higher morbidity and mortality in skin cancer outcomes despite lower lifetime risk.

Related Content

Advertisement

January 12th 2025

Designing Care for the Underserved Creates Higher-Value Health Solutions

Maggie L. Shaw

In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.

December 31st 2024

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

Christina Mattina

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

January 12th 2025

Early Onset Active IBD Linked to Higher Rates of Psychiatric Disorders, Medication Use

Brooke McCormick

Early onset active inflammatory bowel disease (IBD) is associated with significantly higher rates of psychiatric disorders and increased use of psychotropic medications.

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

January 12th 2025

Standardized Measurements Needed for AAVs in Gene Therapy, Study Finds

Rose McNulty

Common measurements for modified adeno-associated viruses (AAVs), a gene therapy delivery method, showed substantial variation in accuracy and precision.

January 11th 2025

Skin Cancer Disparities Persist in Latine/Hispanic Population

Hayden E. Klein

Latine individuals in the US face higher morbidity and mortality in skin cancer outcomes despite lower lifetime risk.